Healthcare Professionals
Latest research
Publications
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.

20 Oct 2021

Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial

written by

Sylvester John E, MD

Matthew R.Smith, Neal Shore, Teuvo L.Tammelac Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Iris Kuss, Marie-Aude Le Berre, Ateesha F.Mohamed, Dawn Odom, Jennifer Bartsch, Amir Snapir, Toni Sarapohja, Karim Fizazi Journal: European Journal of Cancer , volume: Volume 154 , pages 138-146